MedTrace Logo

Culturally Tailored HPV Psychoeducational Multimedia Intervention

NCT06098690 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2026-04-08

No results posted yet for this study

Summary

Community members ages 18 - 45 years old from the El Paso, Texas, U.S.-Mexico Border Region will be recruited to compare psychoeducational multimedia interventions focused on the human papillomavirus (HPV). Our hypothesis is that adults who view culturally tailored multimedia stories encouraging HPV vaccination will report higher vaccine uptake rates.

Conditions

  • Health Knowledge, Attitudes, Practice
  • Vaccine-Preventable Diseases
  • Intention
  • Adherence, Patient

Interventions

BEHAVIORAL

Culturally Tailored Multimedia Psychoeducational HPV Intervention

The culturally tailored multimedia psychoeducational intervention will involve audio and visual content and will be delivered in a bilingual fashion (English and Spanish) among adults 18-45 years-old.

BEHAVIORAL

General HPV Multimedia Psychoeducational Control Group

The general/publicly available multimedia intervention will involve audio and visual content and will be delivered in a bilingual fashion (English and Spanish) among adults 18-45 years-old.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • University of Texas, El Paso

    lead OTHER

Principal Investigators

  • Eva M Moya, PhD, LMSW · The University of Texas at El Paso, Border Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-02
Primary Completion
2024-08-28
Completion
2024-08-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06098690 on ClinicalTrials.gov